---
created: '2026-02-09T05:40:22.072572Z'
description: Nuclear steroid hormone receptor that binds testosterone and DHT. Acts
  as a ligand-activated transcription factor regulating male sexual development and
  prostate cell proliferation.
dg-home: false
dg-publish: true
gardenUsername: dev_admin
permalink: /garden/dev_admin/protein/ar/
slug: ar
tags:
- protein
- receptor
- transcription_factor
- prostate_cancer
- imported
- primekg
templateEngineOverride: njk
title: AR
type: protein
updated: '2026-02-09T05:40:22.072572Z'
---

{% raw %}
<h1>AR</h1>
<h2>Overview</h2>
<p>The <strong>Androgen Receptor (AR)</strong> is a critical transcription factor. In the absence of ligand, it resides in the cytoplasm bound to heat shock proteins (HSP90). Upon binding <strong>Testosterone</strong> or <strong>Dihydrotestosterone (DHT)</strong>, it undergoes a conformational change, dimerizes, and translocates to the nucleus.</p>
<p>In the nucleus, it binds to Androgen Response Elements (AREs) in the promoters of target genes (e.g., PSA/KLK3), driving cell growth and survival.</p>
<h2>Clinical Significance</h2>
<ul>
<li><strong>Prostate Cancer</strong>: AR signaling is the primary driver. Androgen Deprivation Therapy (ADT) works by starving this receptor of ligand. Castration-Resistant Prostate Cancer (CRPC) often involves AR amplification or mutations.</li>
<li><strong>Kennedy's Disease</strong>: Caused by CAG repeat expansion in the AR gene.</li>
</ul>
<!-- NEO4J_CONTENT_START -->
<h2>Relationships</h2>
<h3>Related</h3>
<ul>
<li>→ [[Androgen_Insensitivity_Syndrome]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:48:59.123603'
source: obsidian
</code></pre>
<ul>
<li>→ [[Prostate_Cancer]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:48:59.123603'
source: obsidian
</code></pre>
<ul>
<li>← [[Testosterone]] (hormone)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:48:04.678296'
source: obsidian
</code></pre>
<ul>
<li>→ [[Spironolactone]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:28.960236'
source: obsidian
</code></pre>
<ul>
<li>→ [[Acne]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:28.960236'
source: obsidian
</code></pre>
<ul>
<li>→ [[Bicalutamide]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:28.960236'
source: obsidian
</code></pre>
<ul>
<li>→ [[Enzalutamide]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:28.960236'
source: obsidian
</code></pre>
<ul>
<li>→ [[PSA]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:28.960236'
source: obsidian
</code></pre>
<ul>
<li>→ [[Dihydrotestosterone]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:28.960236'
source: obsidian
</code></pre>
<ul>
<li>→ [[HSP90]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:28.960236'
source: obsidian
</code></pre>
<ul>
<li>→ [[Androgen_Insensitivity_Syndrome]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:28.960236'
source: obsidian
</code></pre>
<ul>
<li>→ [[Prostate_Cancer]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:28.960236'
source: obsidian
</code></pre>
<ul>
<li>→ [[Testosterone]] (hormone)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:28.960236'
source: obsidian
</code></pre>
<ul>
<li>→ [[AR]] (protein)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:45.960358'
source: obsidian
</code></pre>
<!-- NEO4J_CONTENT_END -->
<h2>Relationships</h2>
<h3>Interacts With</h3>
<ul>
<li>← [[Testosterone]] (hormone) - <em>Agonist</em></li>
<li>← [[Dihydrotestosterone]] (hormone) - <em>Potent Agonist</em></li>
<li>→ [[HSP90]] (protein) - <em>Chaperone</em></li>
<li>→ [[PSA]] (protein) - <em>Target Gene Product</em></li>
</ul>
<h3>Targeted By</h3>
<ul>
<li>⊣ [[Enzalutamide]] (drug) - <em>Antagonist</em></li>
<li>⊣ [[Bicalutamide]] (drug) - <em>Antagonist</em></li>
<li>⊣ [[Spironolactone]] (drug) - <em>Weak Antagonist</em></li>
</ul>
<h3>Related Conditions</h3>
<ul>
<li>→ [[Prostate Cancer]] (condition)</li>
<li>→ [[Androgen Insensitivity Syndrome]] (condition)</li>
<li>→ [[Acne]] (condition) - <em>Androgen driven</em></li>
</ul>
<h2>References</h2>
<ol>
<li><strong>UniProt</strong>: P10275 (ANDR_HUMAN)</li>
<li><strong>Review</strong>: Heinlein, C. A., &amp; Chang, C. (2004). &quot;Androgen receptor in prostate cancer.&quot; <em>Endocrine Reviews</em>.</li>
</ol>

{% endraw %}